These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 25265351)
1. Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells. Chekhun SV; Lukyanova NY; Shvets YV; Burlaka AP; Buchinska LG Exp Oncol; 2014 Sep; 36(3):179-83. PubMed ID: 25265351 [TBL] [Abstract][Full Text] [Related]
2. Role of ferritin alterations in human breast cancer cells. Shpyleva SI; Tryndyak VP; Kovalchuk O; Starlard-Davenport A; Chekhun VF; Beland FA; Pogribny IP Breast Cancer Res Treat; 2011 Feb; 126(1):63-71. PubMed ID: 20390345 [TBL] [Abstract][Full Text] [Related]
3. Subtype-specific accumulation of intracellular zinc pools is associated with the malignant phenotype in breast cancer. Chandler P; Kochupurakkal BS; Alam S; Richardson AL; Soybel DI; Kelleher SL Mol Cancer; 2016 Jan; 15():2. PubMed ID: 26728511 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR. Zhang B; Zhao R; He Y; Fu X; Fu L; Zhu Z; Fu L; Dong JT Oncotarget; 2016 Feb; 7(5):5702-14. PubMed ID: 26744318 [TBL] [Abstract][Full Text] [Related]
5. Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD). Sharma P; Kumar S Cell Oncol (Dordr); 2018 Dec; 41(6):637-650. PubMed ID: 30088260 [TBL] [Abstract][Full Text] [Related]
6. Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype. Chekhun S; Bezdenezhnykh N; Shvets J; Lukianova N Exp Oncol; 2013 Sep; 35(3):174-9. PubMed ID: 24084454 [TBL] [Abstract][Full Text] [Related]
8. Influence of ferromagnetic nanocomposite (Ferroplat) on human breast cancer cells of different malignancy degrees: pro/antioxidant balance and energy metabolism. Chekhun VF; Todor IN; Lukianova NY; Horbyk DM; Lozovskaya YV; Burlaka AP; Borikun TV Exp Oncol; 2018 Dec; 40(4):268-274. PubMed ID: 30593756 [TBL] [Abstract][Full Text] [Related]
9. Decreased Iron in Cancer Cells and Their Microenvironment Improves Cytolysis of Breast Cancer Cells by Natural Killer Cells. Jiang XP; Elliott RL Anticancer Res; 2017 May; 37(5):2297-2305. PubMed ID: 28476795 [TBL] [Abstract][Full Text] [Related]
10. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer. Yang DC; Wang F; Elliott RL; Head JF Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801 [TBL] [Abstract][Full Text] [Related]
11. Differential expression of human ferritin H chain gene in immortal human breast epithelial MCF-10F cells. Higgy NA; Salicioni AM; Russo IH; Zhang PL; Russo J Mol Carcinog; 1997 Dec; 20(4):332-9. PubMed ID: 9433477 [TBL] [Abstract][Full Text] [Related]
12. Differential Expression Profiles of the Transcriptome in Breast Cancer Cell Lines Revealed by Next Generation Sequencing. Shi Y; Ye P; Long X Cell Physiol Biochem; 2017; 44(2):804-816. PubMed ID: 29176322 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer. Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633 [TBL] [Abstract][Full Text] [Related]
14. Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity. Linher-Melville K; Nashed MG; Ungard RG; Haftchenary S; Rosa DA; Gunning PT; Singh G PLoS One; 2016; 11(8):e0161202. PubMed ID: 27513743 [TBL] [Abstract][Full Text] [Related]
15. RIP3 overexpression sensitizes human breast cancer cells to parthenolide in vitro via intracellular ROS accumulation. Lu C; Zhou LY; Xu HJ; Chen XY; Tong ZS; Liu XD; Jia YS; Chen Y Acta Pharmacol Sin; 2014 Jul; 35(7):929-36. PubMed ID: 24909514 [TBL] [Abstract][Full Text] [Related]
16. [miR-101 inhibits the proliferation and migration of breast cancer cells via downregulating the expression of DNA methyltransferase 3a]. Liu J; Pang Y; Wang H; Li Y; Sun X; Xu F; Ren H; Liu D Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):299-303. PubMed ID: 26927545 [TBL] [Abstract][Full Text] [Related]
17. The impact of angio-associated migratory cell protein (AAMP) on breast cancer cells in vitro and its clinical significance. Yin Y; Sanders AJ; Jiang WG Anticancer Res; 2013 Apr; 33(4):1499-509. PubMed ID: 23564791 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231. Zhao X; Duan Z; Liu X; Wang B; Wang X; He J; Yao Z; Yang J Anat Rec (Hoboken); 2013 Dec; 296(12):1842-9. PubMed ID: 24155205 [TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer. Piperigkou Z; Franchi M; Götte M; Karamanos NK Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712 [TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231. Suchanek KM; May FJ; Robinson JA; Lee WJ; Holman NA; Monteith GR; Roberts-Thomson SJ Mol Carcinog; 2002 Aug; 34(4):165-71. PubMed ID: 12203367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]